Arovella snaffles R&D rebate worth $3M for cancer cell therapy research
Arovella Therapeutics Ltd (ASX:ALA) has received a $3 million research and development…
Arovella Therapeutics Limited (ASX:ALA)
About Arovella Therapeutics Limited
Key Information
ALA In the News
ASX Announcements
| Date | Announcement | File | Views |
|---|---|---|---|
| 07/03/2025 | Price Sensitive PS S&P DJI Announces March 2025 Quarterly Rebalance | 174.42KB | 486 |
| 05/03/2025 | Top 20 Holders and Range of Units for Attaching Options | 82.61KB | 440 |
| 05/03/2025 | Application for quotation of securities - ALA | 19.09KB | 237 |
| 05/03/2025 | Application for quotation of securities - ALA | 15.75KB | 287 |
| 03/03/2025 | Price Sensitive PS Research Agreement with University of North Carolina | 198.83KB | 430 |
| 03/03/2025 | Letter from Managing Director and CEO | 131.35KB | 13K |
| 27/02/2025 | Price Sensitive PS Half Year Report and Appendix 4D | 3.35MB | 513 |
| 26/02/2025 | Price Sensitive PS Reinstatement to Official Quotation | 85.89KB | 641 |